Cummings Keith Lamont

CIK 00018092041 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001809204

Recent Transactions

50 trades

Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2026-01-20$1.28/sh−24,002→ 297,214 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-23+56,650→ 319,258 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2025-01-23+113,300→ 113,300 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2025-01-17$11.20/sh−20,148→ 262,608 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-10$11.56/sh−10,911→ 282,115 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-07-09+21,313→ 293,026 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-05-02$2.08/sh+21,000→ 271,713 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2024-05-02−21,000→ 76,047 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2024-01-23+110,500→ 110,500 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-23+55,250→ 249,855 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2024-01-17$17.23/sh−9,781→ 194,605 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-17$18.01/sh−19,771→ 203,999 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-07-14+38,750→ 223,770 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-06-13$2.08/sh+30,750→ 185,020 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-13−30,750→ 97,047 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-06-09$2.08/sh+5,800→ 154,270 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-09−5,800→ 127,797 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-30$26.52/sh−9,960→ 148,470 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-03-29+19,375→ 158,430 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-25+54,000→ 138,424 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-25+76,200→ 76,200 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$6.22/sh+17,500→ 114,424 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$2.08/sh+12,500→ 96,924 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-23−17,500→ 18,198 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2023-01-23$35.00/sh−30,000→ 84,424 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2023-01-23−12,500→ 133,597 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-12-22−4,000→ 146,097 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-22$2.08/sh+4,000→ 84,424 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-20$19.10/sh−9,643→ 80,424 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2022-12-19+19,375→ 90,067 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-01-26+124,000→ 124,000 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-09-03−20,000→ 150,097 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2021-09-03$2.08/sh+20,000→ 67,621 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2021-03-05$2.08/sh+20,000→ 47,621 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-03-05−20,000→ 170,097 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-01-23+74,250→ 74,250 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-12-21−4,500→ 190,097 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-21$2.08/sh+4,500→ 27,621 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$2.08/sh+11,591→ 34,712 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-12-01−7,143→ 35,698 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$30.21/sh−14,901→ 23.967 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$30.72/sh−846→ 23,121 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$6.22/sh+7,143→ 41,855 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$29.07/sh−1,848→ 38,868 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-12-01−11,591→ 194,597 total
Sale
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-12-01$28.24/sh−1,139→ 40,716 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-06-05+3,821→ 23,121 total
Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Series C Preferred Stock
2020-06-05−27,322→ 0 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock
2020-04-30$2.08/sh+19,300→ 19,300 total
Exercise/Conversion
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2020-04-30−19,300→ 206,188 total

Companies

PLIANT THERAPEUTICS, INC.
Chief Financial Officer
$PLRX

Recent Filings

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov